Clinical Trials on Control Subjects in United States

Total 15549 results

Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Pharmacokinetics of Tigecycline in Human Bone

Healthy Subjects

United States
GlaxoSmithKline

Completed

To Study And Compare Bioavailability And Safety Of Four Different Formulations Of The Study Drug

Healthy Subjects

United States
Madigan Army Medical Center

Unknown

Efficacy of Silver Nanoparticle Gel Versus a Common Antibacterial Hand Gel

Normal Subjects

United States
Servier Bio-Innovation LLC
Institut de Recherches Internationales Servier

Recruiting

A Phase 1, Open-Label Study to Evaluate the Effect of a Low-Fat Meal and Multiple Doses of Ciprofloxacin on the Pharmacokinetics of Vorasidenib in Healthy Subjects

Healthy Subjects

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)

Healthy Subjects

United States
CTI BioPharma
Covance

Completed

To Evaluate the Cardiac Safety and PK Following a Single Oral Dose Administration of Pacritinib in Healthy Subjects

Healthy Subjects

United States
Carnegie Mellon University

Completed

Mind-body Awareness Training and Brain-computer Interface

Healthy Subjects

United States
Brigham and Women's Hospital

Completed

Effect of Statin Use on Aldosterone Secretion

Healthy Subjects

United States
QT Ultrasound LLC

Active, not recruiting

Clinical PRoduct DevelOpment StudyinG the QT Ultrasound® BReast ScannEr With Volunteer SubjectS (PROGRESS)

Volunteer Subjects

United States
Astellas Pharma Global Development, Inc.

Completed

A Study to Assess the Effect of Food With Fezolinetant in Healthy Female Participants

Healthy Subjects

United States
MacroGenics

Completed

Phase 1 Study of MGD010 in Healthy Subjects

Healthy Subjects

United States
Celldex Therapeutics

Completed

A Phase 1 Study of Subcutaneous CDX-0159 in Healthy Subjects

Healthy Subjects

United States
Venatorx Pharmaceuticals, Inc.

Completed

Safety and Intrapulmonary Pharmacokinetics of Cefepime and Taniborbactam in Healthy Subjects

Healthy Subjects

United States
Cerevel Therapeutics, LLC

Completed

An Open-label Trial to Evaluate Mass Balance of Tavapadon at Steady State in Healthy Subjects

Healthy Subjects

United States
Clinical Nutrition Research Center, Illinois Institute...

Completed

Bioavailability and Pharmacokinetics of Mango (MG)

Healthy Subjects

United States
Procter and Gamble

Completed

Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy Study 2

Healthy Subjects

United States
Cortexyme Inc.

Completed

Study of COR388 HCl in Healthy Subjects

Healthy Subjects

United States
Nicox Ophthalmics, Inc.
ORA, Inc.

Completed

A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution

Healthy Subjects

United States
Eisai Inc.

Completed

A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion

Healthy Subjects

United States
GlaxoSmithKline

Completed

Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol®

Healthy Subjects

United States
Medtronic - MITG

Completed

Pulse Oximetry- Evaluating Resp Rate- PCBA-1

Healthy Subjects

United States
American Regent, Inc.

Completed

Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy Subjects

Healthy Subjects

United States
Puma Biotechnology, Inc.

Completed

Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib

Healthy Subjects

United States
Puma Biotechnology, Inc.

Completed

Study Evaluating TwoTablet Formulations of Neratinib (HKI-272)

Healthy Subjects

United States
GlaxoSmithKline

Completed

GSK1349572 First Time in Human Study

Healthy Subjects

United States
GlaxoSmithKline
Shionogi

Completed

Study to Assess Cardiac Conduction of GSK1349572

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Comparative Formulation Study of Vabicaserin

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Single Doses of BLI-489 in Healthy Subjects

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Pharmacokinetics of Ascending Single IV Doses of ERB-257

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating The Mass Balance And Metabolic Disposition Of SKI-606

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Bosutinib Administered Orally to Healthy Subjects

Healthy Subjects

United States
Avigen

Completed

Study to Examine the Safety, Tolerability, and Pharmacokinetics of AV650

Healthy Subjects

United States
ImmunityBio, Inc.

Recruiting

Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis

Healthy Subjects

United States
CTI BioPharma
Covance

Completed

Drug-Interaction Study to Evaluate the Effect of Rifampin, a Potent CYP3A4 Inducer, on the Systemic Exposure of Pacritinib in Healthy Subjects

Healthy Subjects

United States
BeiGene

Completed

A Pharmacokinetic Study to Assess Drug-drug Interaction Between Zanubrutinib and a Cocktail of Substrates in Healthy Subjects

Healthy Subjects

United States
Duke University

Completed

TMS Modulation of Insula-related Brain Networks.02 (TMSINS02)

Healthy Subjects

United States
Hanmi Pharmaceutical Company Limited

Completed

Molar Potency Study of HM12470 in Healthy Subjects

Healthy Subjects

United States
Kirk A. Frey
Adeptio Pharmaceuticals

Completed

(+)-Alpha-Dihydrotetrabenazine Phase I

Healthy Subjects

United States
University of California, San Francisco

Completed

Effect of Clemastine Fumarate on Color Vision in Healthy Controls

Healthy Subjects

United States
Aerie Pharmaceuticals

Completed

A Controlled Study of the Aqueous Humor Dynamics of AR-13324 Ophthalmic Solution in Healthy Adult Volunteers

Healthy Subjects

United States
Wockhardt
Quintiles, Inc.

Completed

MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults

Healthy Subjects

United States
New Mexico Cancer Care Alliance
Oxnard Foundation

Terminated

Feasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells

Healthy Subjects

United States
AstraZeneca

Terminated

A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy Males

Healthy Subjects

United States
Eisai Inc.

Completed

Randomized, Placebo-controlled Study to Evaluate Effects of E5555 on Renal Function Parameters and OCT2 Activity

Healthy Subjects

United States
Eisai Inc.

Completed

Single and Multiple Dose Asian Bridging Study

Healthy Subjects

United States
GlaxoSmithKline

Completed

A Study to Investigate the Effects of GW876008 on Brain Activation During Emotional Processing in Healthy Subjects.

Healthy Subjects

United States
GlaxoSmithKline

Completed

GSK1349572 Drug Interaction With Tenofovir

Healthy Subjects

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Investigate the Effect of ACT-132577 on the Pharmacokinetics of Midazolam and 1-hydroxy Midazolam in Healthy Male Subjects

Healthy Subjects

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects

Healthy Subjects

United States

3

Subscribe